Triptorelin

63 interactions 4 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Eribulin Injection Ofloxacin Felbamate Oxaliplatin Injection Amisulpride Injection Ivabradine

63 Major

All (63) Major (63)

Major

Triptorelin Amitriptyline Elavil Explained Increased risk of QT interval prolongation Details Triptorelin Sertraline Explained An increased risk of QT interval prolongation Details Triptorelin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Triptorelin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Triptorelin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Triptorelin Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Triptorelin Aripiprazole Injection Abilify Increased risk of QT interval prolongation Details Triptorelin Arsenic Trioxide Injection Trisenox Increased risk of QT interval prolongation Details Triptorelin Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Triptorelin Azithromycin AzaSite Increased risk of QT interval prolongation Details Triptorelin Alfuzosin UroXatral Increased risk of QT interval prolongation Details Triptorelin Anagrelide Agrylin Increased risk of QT interval prolongation Details Triptorelin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Triptorelin Chloroquine Aralen® Increased risk of QT interval prolongation Details Triptorelin Dasatinib Phyrago Increased risk of QT interval prolongation Details Triptorelin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Triptorelin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Triptorelin Disopyramide Norpace Increased risk of QT interval prolongation Details Triptorelin Dofetilide Tikosyn Increased risk of QT interval prolongation Details Triptorelin Dolasetron Anzemet Increased risk of QT interval prolongation Details Triptorelin Dolasetron Injection Anzemet Increased risk of QT interval prolongation Details Triptorelin Encorafenib Braftovi Increased risk of QT interval prolongation Details Triptorelin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Triptorelin Eribulin Injection Halaven Increased risk of QT interval prolongation Details Triptorelin Famotidine Calmicid Increased risk of QT interval prolongation Details Triptorelin Famotidine Injection Calmicid Increased risk of QT interval prolongation Details Triptorelin Felbamate Felbatol Increased risk of QT interval prolongation Details Triptorelin Flecainide Tambocor® Increased risk of QT interval prolongation Details Triptorelin Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Triptorelin Fostemsavir Rukobia Increased risk of torsade de pointes Details Triptorelin Galantamine Razadyne Increased risk of QT interval prolongation Details Triptorelin Gatifloxacin Ophthalmic Zymar® Increased risk of QT interval prolongation Details Triptorelin Gemifloxacin Factive Increased risk of QT interval prolongation Details Triptorelin Glasdegib Daurismo Increased risk of QT interval prolongation Details Triptorelin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Triptorelin Granisetron Transdermal Patch Sancuso Increased risk of QT interval prolongation Details Triptorelin Granisetron Injection Granisol Increased risk of QT interval prolongation Details Triptorelin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Triptorelin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Triptorelin Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.